Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 10 October 2025
Revised: 19 December 2025
Accepted: 5 January 2026
First Online: 13 February 2026
Compliance with ethical standards
:
: The scientific guarantor of this publication is Carlo A. Mallio.
: The authors of this manuscript declare relationships with the following companies: Carlo A. Mallio: none. Giles Roditi: served as the United Kingdom Principal Investigator for the Phase III Gadoquatrane study supported by Bayer, without receiving personal remuneration. Aart J. van der Molen: none.
: No complex statistical methods were necessary for this paper.
: Written informed consent was not required.
: Institutional Review Board approval was not required.
: Not applicable.
:
